Irenic Acquisition

This filing is the SPAC's birth certificate as a public company. For investors monitoring the redemption calendar, it is critical because it sets the trust value per share at $10.06 as of IPO (based on user data; per the filing, $10.00 per unit was deposited) and the initial deadline to complete a business combination at 24 months from closing (April 2028). It also reveals sponsor conduct: the sponsor and insiders signed a letter agreement agreeing to vote in favor of a deal and to not redeem their founder shares. Furthermore, it discloses a forward purchase agreement with an affiliate to buy $50 million in units at closing of a business combination, subject to investment committee approval, providing additional committed capital.

This filing establishes the core redemption mechanics, trust value, and sponsor incentives for the SPAC. The trust per-share value is initially $10.00, but the sponsor's founder shares were acquired at a nominal cost, creating potential dilution and conflicts of interest. The forward purchase agreement provides a $50 million backstop for a business combination. The 24-month deadline and the 15% redemption cap per shareholder (without consent) are key structural features. Investors should note the absence of a target and the broad discretion of management to identify a target in aerospace, defense, or industrial sectors.

This conditional $50,000,000 equity bridge protects the $10.06 trust floor from dilution because funds remain escrowed and return to the purchaser if the merger fails, while simultaneously providing working capital for transaction execution. Other substantive terms include a fully itemized $1,000,000 issuance cost breakdown (legal fees $375,000, SEC/FINRA expenses $101,330, misc $342,670, etc.), indemnification limits capping director/officer liability outside the trust, exclusive New York jurisdiction, jury trial waivers, and registration rights for forward securities. Execution and oversight are attributed to CEO Adam Katz and CFO Matthew Kupersmith.

Establishes the full mechanics for IACQ: IPO size, trust value per share, sponsor economics (21% post-IPO ownership), forward purchase backstop, target focus on aerospace/defense/industrial, management team bios from Irenic Capital (Adam Katz, E-Fei Wang, Matthew Kupersmith) and independent directors with aerospace/industrial backgrounds. Provides redemption mechanics, extension procedures, dilution tables, and risk factors. The $50M forward purchase from Irenic's own fund is a meaningful alignment signal trust/share = $10.06.

Investors now have the full terms of the SPAC: trust value of $10.00 per public share (not $10.06 as stated in the query; the document shows $10.00 per share), a 24-month completion deadline from the closing of the offering (the query's 2028-04-28 deadline is an estimate, not in the document), a $50 million forward purchase commitment from an affiliate fund, a 15% cap on redemptions if a shareholder vote is used, and significant sponsor compensation (founder shares purchased for ~$0.004 per share). The filing also details sponsor conduct, including lock-up provisions, conflict of interest disclosures, and indemnification arrangements.

What changed: Form 8-K current report and accompanying press release announcing the separate listing and trading commencement of Irenic Acquisition Corp.’s Class A ordinary shares and warrants, decoupled from its initial public offering units. No adjustment to the redemption deadline, trust account balance, extension mechanism, business combination status, or sponsor management. The sole mechanical change is that each IPO Unit—defined as one Class A ordinary share with a $0.0001 par value paired with one-third of one redeemable warrant—may now be structurally separated into independent securities beginning June 18, 2026. Upon separation, standalone shares will trade under the ticker IACQ, standalone warrants under IACQW at an $11.50 exercise price, and any remaining unsplitted units will continue trading as IACQU. The filing specifies that no fractional warrants will be issued and requires unit holders to instruct their brokers to coordinate with transfer agent Continental Stock Transfer & Trust Company to execute the split. Why it matters: This procedural announcement alters secondary-market liquidity options without modifying redemption thresholds, trust protections, or the search timeline. Existing unit holders can now isolate pure equity positions or acquire leveraged warrant exposure, which typically influences pair-trading dynamics and reduces unit premium/discount compression. Additionally, a press release included as Exhibit 99.1 and attributed to sponsor Longacre Square Partners (contacted via Dan Zacchei and Ashley Areopagita) confirms the sponsor’s ongoing operational posture, stating the company currently intends to focus on target businesses in the aerospace, defense, and broader industrial sectors. The CFO Matthew Kupersmith executed the report, signaling routine administrative compliance rather than strategic pivot, litigation, partnership shift, or financial milestone disclosure.

What changed: SEC Form 8-K current report filed by Irenic Acquisition Corp. disclosing the April 29, 2026 consummation of its initial public offering, the May 1, 2026 partial exercise and closing of the underwriters’ over-allotment option, supplemented by an audited balance sheet dated April 29, 2026 and a May 1, 2026 press release issued by the Company. The Company states that on April 29, 2026, it consummated its IPO of 22,000,000 units at $10.00 per unit, generating $220,000,000 in gross proceeds and depositing $220,000,000 into a trust account maintained by Continental Stock Transfer & Trust Company at J.P. Morgan Chase Bank, N.A. On May 1, 2026, the registrant reports that underwriters partially exercised the over-allotment option, selling 3,253,188 additional units at $10.00 each for $32,531,880 in gross proceeds. The Company states that $32,531,880 of net proceeds from this transaction and additional private placements were deposited into the trust account, bringing the aggregate trust deposit to $252,531,880. The registrant discloses that, concurrent with the over-allotment closing, the Sponsor purchased 32,532 private placement units and the underwriters purchased another 32,532. In connection with the partial exercise, the Company states the Sponsor forfeited 11,703 founder shares, resulting in the Sponsor holding 6,313,297 founder shares. The financial statements report total transaction costs of $13,850,913, broken down by the registrant into $4,400,000 upfront underwriting discounts, $8,800,000 deferred underwriting commissions, and $650,913 other offering costs. As of April 29, 2026, the Company’s balance sheet reflects $1,087,383 in cash, $977,288 in working capital, and a shareholders’ deficit of $(7,706,462). The registrant confirms the Completion Window allows 24 months from the April 29, 2026 IPO closing to complete a business combination. Why it matters: This filing recalibrates the post-offering liquidity and structural parameters governing redemptions and sponsor economics. The Company’s disclosure that the trust account now holds $252,531,880 establishes the precise capital pool available for shareholder payouts or acquisition funding before any operational draws. The registrant’s confirmation of the 6,313,297 founder share count (following the forfeiture of 11,703 shares) defines the Sponsor’s baseline equity retention and voting weight post-deal. By documenting $13,850,913 in transaction costs, the Company clarifies the gap between gross capital raised and net deployable funds, directly impacting sponsorship incentives and target pricing tolerance. The audited financials show zero Working Capital Loans to date, while noting up to $1,500,000 may be convertible into post-combination private units, highlighting potential future dilution pathways. The registrant’s press release and Notes disclose a $50,000,000 forward purchase commitment from Irenic Capital Evergreen Master Fund LP, subject to its investment committee’s approval, which would supply targeted capital if public redemptions constrain trust liquidity. The Company also commits to paying $20,000 per month in administrative fees to the Sponsor and Irenic Capital Management LP until combination or liquidation. According to the press release, the registrant intends to focus its search on aerospace, defense, and broader industrial sectors. The underwriters, Jefferies and Odeon Capital Group LLC, have waived rights to the $8,800,000 deferred underwriting commission if the business combination is not completed within the 24-month window, aligning their payout strictly with successful execution.

What changed: A Form 8-K current report filed by Irenic Acquisition Corp. disclosing the closing of the underwriters’ partially exercised over-allotment option, concurrent private placement transactions, trust account funding adjustments, sponsor founder share forfeitures, and accompanying unaudited pro forma balance sheet information. CEO Adam Katz, on behalf of the registrant, reports that on May 1, 2026, the Company closed the issuance of 3,253,188 Over-Allotment Option Units at $10.00 per Unit, generating gross proceeds of $32,531,880. The underwriters forfeited their option to purchase 46,812 remaining Units. Simultaneously, the Company sold 65,064 additional Private Placement Units at $10.00 per unit: 32,532 units to Irenic Sponsor, LLC and 32,532 units to Jefferies LLC and Odeon Capital Group LLC, yielding $650,640. Cash deposited into the Trust Account at J.P. Morgan Chase Bank, N.A. totaled $32,531,880 from the over-allotment, bringing the aggregate proceeds in the Trust Account to $252,531,880 (Exhibit 99.1 reflects $252,531,882). Class A ordinary shares subject to possible redemption are now 25,253,188 shares at a stated redemption value of $10.00 per share. Each whole warrant entitles holders to purchase one Class A ordinary share at an exercise price of $11.50 per share. The Sponsor forfeited 11,703 Class B ordinary founder shares due to the partial over-allotment exercise, leaving the Sponsor with an aggregate of 6,313,297 founder shares. The deferred underwriting fee payable increased by $1,301,275 to $10,101,275. The filing notes no changes to the April 28, 2028 business combination deadline and does not identify a target company. Why it matters: This filing finalizes the post-IPO capital structure, locking the exact trust balance ($252,531,880/$252,531,882), redeemable share count (25,253,188), and deferred compensation liability ($10,101,275) that dictate shareholder liquidation floors and deal financing math ahead of any merger vote. The sponsor and lead underwriters’ continued acquisition of 452,532 total private placement units at $10.00 each, alongside the dilutive forfeiture of 11,703 founder shares, demonstrates ongoing economic alignment per the registration statement mechanics. The underwriters’ decision to exercise only 3,253,188 of the 3,300,000 available over-allotment units signals measured demand without triggering timeline extensions. Beyond capital mechanics, the document contains no claims regarding prospective customers, revenue projections, market size, target industry strategy, proprietary technology, named partnerships, active litigation, or executive compensation changes; the registrant remains in a pre-target search phase with all substantive disclosures limited to securities issuance, trust administration, and structural equity adjustments as reported by management.

What changed: A Schedule 13G Joint Filing Agreement. According to the Joint Filing Agreement executed on May 4, 2026, by Gil Raviv (Global General Counsel) for Millennium Management LLC and Millennium Group Management LLC, and by Israel A. Englander, the parties consolidated their beneficial ownership reporting for Class A Ordinary Shares, par value $0.0001 per share, into a single SEC submission pursuant to Rule 13d-1(k). This document contains no share quantities, percentage thresholds, or valuation metrics, and therefore reports no alterations to redemption deadlines, trust account distribution mechanics, extension provisions, business combination target selection, or sponsor conduct. Beyond the procedural consolidation of the filing, the text discloses only that the named entities have reached a reporting obligation; no claims concerning customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes are present. Why it matters: As stated in the agreement, this instrument merely establishes that Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander will jointly satisfy their 13G disclosure requirements for the SPAC's ordinary shares. While the document itself does not specify the aggregate stake held or indicate whether the group intends to participate actively in the merger process, historical precedent shows that institutional 13G filings at the searching stage often precede anchor investor announcements or reflect passive portfolio rebalancing. Investors should treat this as a baseline compliance step and monitor subsequent Schedule 13G/A amendments to determine whether Millennium is accumulating enough shares to cross the 20% voting threshold or remains below it, as that trajectory will ultimately dictate whether their holdings can influence redemption outcomes or settlement conditions once a target is identified.

What changed: Schedule 13D beneficial ownership report. This SEC filing discloses a beneficial ownership position crossing the five-percent threshold, mandating public revelation of the acquiring party, share quantity, and transaction basis. The structured holder table containing exact share counts, acquisition dates, and per-share pricing is explicitly noted as absent from this XML variant, meaning no verifiable changes to trust composition, redemption exposure, or sponsor governance allocation can be extracted from this excerpt. Why it matters: For a SPAC currently in SEARCHING status, the formation of a >5% blockholder directly impacts redemption timeline modeling, extension voting mathematics, and pre-deal negotiation leverage. A new major investor may align with sponsors on target selection, accumulate positions ahead of a business combination announcement, or structure holdings to contest proposed liquidation distributions. Because this extract omits the acquisition purpose, source of funds, and precise entry price relative to trust value, the filing does not yet establish whether the position represents passive indexing, activist positioning, or coordinated deal financing. Investors should monitor the complete dataset or subsequent amendments to determine how the blockholder intends to interact with upcoming shareholder votes, potential trust withdrawals, or any announced merger roadmap.(flagged for human review)

What changed: Routine compliance exhibit (Form 4 — insider ownership report). First, this filing identifies as a regulatory submission recording Section 16(a) insider transactions. Second, regarding redemption deadlines, trust value, extensions, deal progress, and sponsor conduct: according to the Form 4 disclosure, Irenic Sponsor, LLC (attributed as a 10% owner and Director by Deputization) and director/CEO Adam J. Katz reported that on 2026-05-01 they acquired 32,532 shares at $10 per share via grant/award, resulting in a combined post-transaction holding of 452,532 shares. The submission does not amend the stated trust/share value of $10.06, does not propose or necessitate action on the 2028-04-28 business combination deadline, and confirms the issuer remains in SEARCHING status with no target identified or extension vote scheduled. Third, regarding additional substance: the document contains no claims concerning customers, revenue, market size, strategic direction, technology, partnerships, litigation, or personnel shifts beyond the equity accumulation attributed to the sponsoring manager and chief executive officer. Why it matters: Investors tracking the specified mechanics will note zero impact on trust preservation, redemption pricing, or timeline enforcement. The equity grant demonstrates sponsor alignment through direct share accumulation during the pre-dealt phase, executed entirely outside trust accounts and requiring no shareholder approval. Because the report solely records administrative issuance of compensation awards, it does not independently signal deal initiation, alter investor protection covenants, or mandate distribution adjustments.

What changed: An 8-K Current Report filed by newly-public SPAC Irenic Acquisition Corp. consummating its initial public offering (IPO) and entering into the related set of foundational agreements. The document reports the consummation of IACQ's IPO of 22,000,000 units (each unit one share + 1/3 warrant) at $10.00 per unit. It establishes a trust account with $220,000,000 ($10.00 per share) and a 24-month deadline (April 2028). It details the board, lock-ups, sponsor terms, a forward purchase agreement with an affiliate, and the standard suite of SPAC IPO agreements. Why it matters: This filing is the SPAC's birth certificate as a public company. For investors monitoring the redemption calendar, it is critical because it sets the trust value per share at $10.06 as of IPO (based on user data; per the filing, $10.00 per unit was deposited) and the initial deadline to complete a business combination at 24 months from closing (April 2028). It also reveals sponsor conduct: the sponsor and insiders signed a letter agreement agreeing to vote in favor of a deal and to not redeem their founder shares. Furthermore, it discloses a forward purchase agreement with an affiliate to buy $50 million in units at closing of a business combination, subject to investment committee approval, providing additional committed capital.

What changed: SEC Form 4 insider ownership report [0001104659-26-051611]. Per the Form 4, on 2026-04-27 Irenic Sponsor, LLC (identified as a 10% owner and Director by Deputization) and director/Chief Executive Officer Adam J. Katz acquired 420,000 shares at $10 per share via grant/award, leaving them owning 420,000 shares total. The trust/share remains $10.06, the liquidation deadline remains 2028-04-28, and the issuer’s status remains SEARCHING. No changes to redemption windows, proxy schedules, or trust distribution mechanics are disclosed. Why it matters: The filing documents sponsor-side equity accumulation without touching public shareholder redemption rights or the $10.06 trust allocation. Because the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel shifts beyond the executive titles listed, it offers no incremental signal on deal progress, valuation targets, or extension likelihood. Investors tracking redemption deadlines and sponsor conduct will see only a routine capitalization adjustment: the sponsor and CEO now hold 420,000 founder shares purchased at $10, which does not alter the 2028-04-28 liquidation timeline or trigger mandatory redemption pricing adjustments.

What changed: Prospectus (424B4) filed pursuant to Rule 424(b)(4) for the initial public offering of Irenic Acquisition Corp., a blank check company incorporated in the Cayman Islands, formed to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. The SPAC has not selected any target and has not engaged in substantive discussions with any target. This is the final prospectus for the IPO, confirming the offering of 22,000,000 units at $10.00 per unit, with $220,000,000 deposited in the trust account ($10.00 per public share). The SPAC has a 24-month completion window from the closing of this offering (expected April 2028) and may seek shareholder approval to extend (not expected beyond 36 months). No target has been identified. The forward purchase agreement with Irenic Capital Evergreen Master Fund LP for $50,000,000 (5,000,000 forward purchase units at $10.00 per unit) is disclosed, subject to investment committee approval. Sponsor's founder shares were purchased for $25,000 ($0.004 per share) and sponsor will purchase 420,000 private placement units at $10.00 per unit. The underwriters will purchase 220,000 private placement units. The prospectus also details the 15% per-shareholder redemption limit, waiver of redemption rights by sponsor and officers for founder shares and private placement shares, and lock-up provisions. Why it matters: This filing establishes the core redemption mechanics, trust value, and sponsor incentives for the SPAC. The trust per-share value is initially $10.00, but the sponsor's founder shares were acquired at a nominal cost, creating potential dilution and conflicts of interest. The forward purchase agreement provides a $50 million backstop for a business combination. The 24-month deadline and the 15% redemption cap per shareholder (without consent) are key structural features. Investors should note the absence of a target and the broad discretion of management to identify a target in aerospace, defense, or industrial sectors.

What changed: SEC Form 3 — initial statement of beneficial ownership of securities. This routine compliance exhibit reports zero insider activity for Director and President Wang E-Fei. The filing explicitly states 'No non-derivative transactions or holdings reported,' meaning there is no change to sponsor or officer equity positions, no adjustment to the trust account, no proposal to alter the business combination deadline, no progression toward a target acquisition, and no shift in sponsor conduct or governance posture. Why it matters: Beyond listing the issuer name and the reporting individual’s title, the text contains no claims, projections, or disclosures regarding customer concentration, revenue streams, addressable market size, technology development, partnership agreements, ongoing litigation, or executive succession plans. Because no assertions were advanced by management, directors, or third parties within this document, there are no strategic inflection points, operational metrics, or behavioral red flags to weigh against the existing redemption calendar or valuation framework. The filing functions solely as a regulatory record confirming unchanged insider ownership without introducing new capital dynamics or commercial narratives.